安徽医学
安徽醫學
안휘의학
ANHUI MEDICAL JOURNAL
2015年
4期
466-468
,共3页
申辉%韩明锋%腾小宝%赵凤德%时靖峰
申輝%韓明鋒%騰小寶%趙鳳德%時靖峰
신휘%한명봉%등소보%조봉덕%시정봉
支气管扩张%感染%病原学%药物敏感试验
支氣管擴張%感染%病原學%藥物敏感試驗
지기관확장%감염%병원학%약물민감시험
Bronchiectasis%Infection%Etiology%Microbial sensitivity tests
目的:分析118例支气管扩张合并感染住院患者的病原学及药敏情况,以指导临床抗菌药物的应用。方法对因支气管扩张合并感染需要住院的118例患者的痰培养和药敏结果进行回顾分析。结果118例痰培养68例阳性,阳性率为57.6%,其中革兰阴性菌66株,占97.0%,最常见的病原菌为铜绿假单孢菌,对第三、四代头孢菌素、氟喹诺酮类、氨基糖甙类、碳青霉烯类抗菌药物敏感。结论支气管扩张患者病原菌分布以革兰阴性杆菌为主,尤其铜绿假单孢菌感染。在药敏结果未报告前,可经验选择第三、四代头孢菌素、碳青霉烯类、氟喹诺酮类或氨基糖甙类抗菌药物。
目的:分析118例支氣管擴張閤併感染住院患者的病原學及藥敏情況,以指導臨床抗菌藥物的應用。方法對因支氣管擴張閤併感染需要住院的118例患者的痰培養和藥敏結果進行迴顧分析。結果118例痰培養68例暘性,暘性率為57.6%,其中革蘭陰性菌66株,佔97.0%,最常見的病原菌為銅綠假單孢菌,對第三、四代頭孢菌素、氟喹諾酮類、氨基糖甙類、碳青黴烯類抗菌藥物敏感。結論支氣管擴張患者病原菌分佈以革蘭陰性桿菌為主,尤其銅綠假單孢菌感染。在藥敏結果未報告前,可經驗選擇第三、四代頭孢菌素、碳青黴烯類、氟喹諾酮類或氨基糖甙類抗菌藥物。
목적:분석118례지기관확장합병감염주원환자적병원학급약민정황,이지도림상항균약물적응용。방법대인지기관확장합병감염수요주원적118례환자적담배양화약민결과진행회고분석。결과118례담배양68례양성,양성솔위57.6%,기중혁란음성균66주,점97.0%,최상견적병원균위동록가단포균,대제삼、사대두포균소、불규낙동류、안기당대류、탄청매희류항균약물민감。결론지기관확장환자병원균분포이혁란음성간균위주,우기동록가단포균감염。재약민결과미보고전,가경험선택제삼、사대두포균소、탄청매희류、불규낙동류혹안기당대류항균약물。
Objective To investigate the etiology and antibiotic susceptibility in patients with bronchiectasis complicated by severe infection treated in Fuyang No. 2 hospital in 2013 to indicate the use of antibiotics. Methods Data of sputum culture and antibiotic suscepti-bility of 118 patients with boron complicated by severe infection were retrospectively analyzed. Results Positive sputum culture was obtained in 68 patients with the positive rate of 57. 6%. There were 66 stains of gram negative bacteria(97. 0%). Pseudomonas aeruginosa were the most common pathogens and had high sensitivity with cefozolin of III,IV,quinolones,aminoglycosides,carbopenems. Conclusion Gram-negative bacteria,especially pseudomonas aeruginosa are the main pathogens found in bronchiectasis patients. Before the report of suscepti-bility results,the cefozolin of III,IV,quinolones,aminoglycosides,carbopenems are experiential options.